Crossmark

Strontium-doped hydroxyapatite nanocomposites for breast cancer bone metastasis therapy by modulating bone formation and suppressing cancer cell stemness

Crossref DOI link: https://doi.org/10.1007/s11051-025-06407-x

Published Online: 2025-09-16

Published Print: 2025-10

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Lu, Yanlian

Liu, Zhengjie

Ji, Mengmeng

Ren, Lili

Song, Yanru

Zhou, Guoqiang

Yang, Hua

Ge, Kun
Funding

Funding for this research was provided by:

Medical Talent Foundation of Health Commission of Hebei Province (ZF2025258)

National Natural Science Foundations of China (21807023)
License Information

Text and Data Mining valid from 2025-09-16

Version of Record valid from 2025-09-16
More Information

Article History

Received: 17 June 2025

Accepted: 21 July 2025

First Online: 16 September 2025

Declarations

:

: The authors declare no competing interests.

Document is current

Any future updates will be listed below